Indivior (LON:INDV) Trading Down 15.7% – Time to Sell?

Indivior PLC (LON:INDV)’s stock price fell 15.7% during trading on Friday . The company traded as low as GBX 548.71 ($6.95) and last traded at GBX 732 ($9.28). 1,888,371 shares were traded during trading, an increase of 166% from the average session volume of 709,477 shares. The stock had previously closed at GBX 868 ($11.00).

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 1,800 ($22.81) price target on shares of Indivior in a research report on Tuesday, December 17th.

Indivior Price Performance

The stock has a market capitalization of £1.08 billion, a price-to-earnings ratio of -571.70, a P/E/G ratio of -5.57 and a beta of 0.19. The company has a quick ratio of 1.52, a current ratio of 0.83 and a debt-to-equity ratio of -170.06. The business’s 50 day simple moving average is GBX 924.76 and its 200-day simple moving average is GBX 852.88.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.